Affiliation:
1. School of Science, Constructor University, Campus Ring 1, 28759 Bremen, Germany
Abstract
A series of new aromatic substituted indanone and indanol building blocks have been prepared and are anticipated to aid future drug discovery studies. In total, seven compounds (7, 12–17) are expounded on, and all have been fully characterized. In doing so, we have shown multiple examples of highly chemoselective reactions. One example employed an adaptation of Fujioka’s chemoselective reduction methodology, allowing an ester to be reduced in the presence of a ketone. In another example, an uncommon benzylic methyl group to aldehyde oxidation was demonstrated for two different compounds. These and other chemoselective interconversions allowed us to identify compound (12) as a remarkably flexible springboard for accessing a diverse array of indan-based building blocks (13–17).
Funder
Deutsche Forschungsgemeinschaft
Reference33 articles.
1. Schwink, L., Buning, C., Glombik, H., Gossel, M., Kadereit, D., Halland, N., Lohmann, M., Pöverlein, C., and Ritter, K. (2015). Substituted Indanone Compounds as GPR119 Modulators for The Treatment of Diabetes, Obesity, Dyslipidemia, and Related Disorders. (2015150563 A1), WO Patent.
2. New Serotonin 5-HT2A, 5-HT2B, and 5-HT2C Receptor Antagonists: Synthesis, Pharmacology, 3D-QSAR, and Molecular Modeling of (Aminoalkyl)benzo and Heterocycloalkanones;Brea;J. Med. Chem.,2002
3. Synthesis of New 6-Substituted Purinyl-5′-nor-1′-homocarbanucleosides Based on Indanol;Morales;Tetrahedron,2004
4. Synthesis and Antiviral Activities of Novel Purinyl- and Pyrimidinylcarbanucleosides Derived from Indan;Alonso;Synthesis,2008
5. Identification and Preliminary Structure–Activity Relationships of 1-Indanone Derivatives as Novel Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors;Gao;Bioorg. Med. Chem.,2017